Are Biosimilars the Next Big Thing in Biotech?
Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?
Illumina's Earnings Set Positive Tone for Biotech
What's behind Illumina's remarkable earnings beat, and what could it mean for biotech stocks?
Is Immuno-Oncology the Best Area of Biotech to Invest in Right Now?
Immuno-oncology has become a major focus among big pharma companies these days. Should investors jump on this trend?